• Latest Posts

Innovent and IASO Bio obtain approval for CAR-T multiple myeloma treatment 

Kelonia presents ‘compelling evidence’ for transformative multiple myeloma treatment

Five advancements in lupus research over the past year

In Depth 3 May 2023

Immunotherapy in the fight against solid tumors

Cabaletta Bio’s lupus drug cleared for trial

10 immunotherapy companies making waves in 2023


How the microbiome can predict cancer immunotherapy success

Peter MacCallum Cancer Centre and Cartherics to work on CAR-T cell therapy for ovarian cancer

Interview 17 Feb 2023

The benefits – and challenges – of in-house CAR T-cell therapy

Sponsored by 7 Feb 2023

Streamlining CAR-T cell therapy manufacturing: a platform approach

Poolbeg expands POLB 001 into oncology

Cartherics granted first patent in China